News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
Promoting scientific careers in times of COVID-19
Promoting scientific careers in times of COVID-19
The Barcelona Science Park kicks off the 17th Batx2Lab, a pioneering programme which has inspired…
Cleanroom at VIVEbiotech
VIVEbiotech collaborates with Xyphos Biosciences for clinical development support of convertibleCAR-T™ cell therapy
VIVEbiotech, S.L. announces a collaboration with Xyphos Biosciences for the development its CAR-T™…
La biotecnología lidera la lucha frente el coronavirus
Biotechnology leads the fight against new coronavirus
Coronavirus
The National Center for Biotechnology-CSIC, the Carlos III Health Institute and the Biomedical…
Validation batches of the vaccine against equine strangles Strangvac is completed
Validation batches of the vaccine against equine strangles Strangvac is completed
3P Biopharmaceuticals together with the Swedish biotechnology company Intervacc AB and LIOF-…
XIII Spanish-Portuguese Conference on Controlled Drug Delivery
XIII Spanish-Portuguese Conference on Controlled Drug Delivery
XIIIth Spanish-Portuguese Conference on Controlled Drug Delivery will be held from January 22-…
Workshop in Morocco
BIOLAN PARTICIPATES IN TRAINING ORGANIZED BY AHP (Agadir Hliopole Cluster) IN COLLABORATION WITH ONSSA.
dreamgenics-turns-8
DREAMgenics turns 8
Algenex and FATRO sign commercial license agreement for development of a second CrisBio -based vaccine
Algenex and FATRO sign commercial license agreement for development of a second CrisBio -based vaccine
Agreement strengthens collaboration between the companies following submission of the first dossier…
ZYMVOLteam
European Commission awards ZYMVOL Biomodeling with H2020 SME Instrument Phase II (1,3 M€)
It´s for the project “UNLOCK-EDD: UNLOCK next generation computer guided Enzyme Discovery &…